share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Officer Gibbs Michael Terrence

SEC announcement ·  Feb 21 05:04
Summary by Futu AI
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 20, 2024, involving the acquisition of 40 shares of common stock. The transaction, classified under the code 'M', indicates an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 106 shares in the company. The action reflects a continued investment by a key insider in the firm's equity.
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 20, 2024, involving the acquisition of 40 shares of common stock. The transaction, classified under the code 'M', indicates an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 106 shares in the company. The action reflects a continued investment by a key insider in the firm's equity.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.